Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : LastShadow's Position Trading -- Ignore unavailable to you. Want to Upgrade?

To: Susan Saline who wrote (23633)	10/20/1999 10:03:00 PM
From: LastShadow	Read Replies (1) \| Respond to of 43080

What? Ok, I'm tired, what did I do now?

To: Susan Saline who wrote (23633)	10/20/1999 11:08:00 PM
From: AlienTech	Respond to of 43080

I think its temporary! Greenie does wonders for the pharma industry.. On the next @Show... Where, If you aint doing it, You aint with it and you aint in it and if you aint in it you aint not on it. Pass the demerol buddy.. hic Prozac depresses Lilly Also: Nearly unanimous on MSFT; Advanced Fibre slides By Susan Lerner, CBS MarketWatch Last Update: 4:50 PM ET Oct 20, 1999 Analysts Ratings Market Pulse NEW YORK (CBS.MW) -- Eli Lilly shares showed signs of depression Wednesday as investors focused on slowing prozac sales, prompting a Salomon Smith Barney downgrade. cbs.marketwatch.com